North America Newborn Screening Market Size & Outlook
North America newborn screening market, 2018-2030 (US$M)
Related Markets
North America newborn screening market highlights
- The North America newborn screening market generated a revenue of USD 132.1 million in 2023.
- The market is expected to grow at a CAGR of 7.5% from 2024 to 2030.
- In terms of segment, tandem mass spectrometry was the largest revenue generating technology in 2023.
- Electrophoresis is the most lucrative technology segment registering the fastest growth during the forecast period.
- Country-wise, Canada is expected to register the highest CAGR from 2024 to 2030.
North America data book summary
| Market revenue in 2023 | USD 132.1 million |
| Market revenue in 2030 | USD 219.3 million |
| Growth rate | 7.5% (CAGR from 2023 to 2030) |
| Largest segment | Tandem mass spectrometry |
| Fastest growing segment | Electrophoresis |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Tandem Mass Spectrometry, Pulse Oximetry, Enzyme-based Assay, DNA Assays, Electrophoresis |
| Key market players worldwide | Bio-Rad Laboratories Inc, Agilent Technologies, Agilent Technologies Inc, Covidien, Masimo Corp, Waters Corp, Natus Medical, GE HealthCare Technologies Inc Common Stock, PerkinElmer, Danaher Corp |
Other key industry trends
- In terms of revenue, North America region accounted for 16.6% of the global newborn screening market in 2023.
- Globally, Asia Pacific is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 451.1 million by 2030.
Tandem mass spectrometry was the largest segment with a revenue share of 24.6% in 2023. Horizon Databook has segmented the North America newborn screening market based on tandem mass spectrometry, pulse oximetry, enzyme-based assay, dna assays, electrophoresis covering the revenue growth of each sub-segment from 2018 to 2030.
Newborn screening program is diligently followed in all the states of North America. According to statistics published by CDC’s in 2013, more than four million babies born annually are screened for various possible conditions.
Recently, ACMG has deviated from the traditional screening criteria and added new conditions to the list. Hearing screen was added in 2011. Congenital disorders left undetected may lead to arrested mental and physical development, hampering the life-long health of individuals.
North America is highly active in its aim to retain health and well-being of future citizens, and has advocacy groups and federal government, which provide funding to promote market growth. The National Association for Retarded Citizens (NARC) along with Public Health Services have initiated pilot diagnoses program in collaboration with state laboratories.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Newborn Screening Market Scope
Newborn Screening Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
North America newborn screening market size, by country, 2018-2030 (US$M)
North America Newborn Screening Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
